BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 11454846)

  • 1. Magnesium causes nitric oxide independent coronary artery vasodilation in humans.
    Teragawa H; Kato M; Yamagata T; Matsuura H; Kajiyama G
    Heart; 2001 Aug; 86(2):212-6. PubMed ID: 11454846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flow-mediated vasodilation of human epicardial coronary arteries: effect of inhibition of nitric oxide synthesis.
    Shiode N; Morishima N; Nakayama K; Yamagata T; Matsuura H; Kajiyama G
    J Am Coll Cardiol; 1996 Feb; 27(2):304-10. PubMed ID: 8557898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leptin causes nitric-oxide independent coronary artery vasodilation in humans.
    Matsuda K; Teragawa H; Fukuda Y; Nakagawa K; Higashi Y; Chayama K
    Hypertens Res; 2003 Feb; 26(2):147-52. PubMed ID: 12627874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adrenomedullin causes coronary vasodilation in humans: effects of inhibition of nitric oxide synthesis.
    Ueda K; Teragawa H; Kimura M; Matsuda K; Higashi Y; Yamagata T; Oshima T; Yoshizumi M; Chayama K
    J Cardiovasc Pharmacol; 2005 Oct; 46(4):534-9. PubMed ID: 16160609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bradykinin induced dilatation of human epicardial and resistance coronary arteries in vivo: effect of inhibition of nitric oxide synthesis.
    Kato M; Shiode N; Yamagata T; Matsuura H; Kajiyama G
    Heart; 1997 Nov; 78(5):493-8. PubMed ID: 9415011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tetrahydrobiopterin restores endothelial function of coronary arteries in patients with hypercholesterolaemia.
    Fukuda Y; Teragawa H; Matsuda K; Yamagata T; Matsuura H; Chayama K
    Heart; 2002 Mar; 87(3):264-9. PubMed ID: 11847169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of inhibition of nitric oxide synthesis on epicardial coronary artery caliber and coronary blood flow in humans.
    Lefroy DC; Crake T; Uren NG; Davies GJ; Maseri A
    Circulation; 1993 Jul; 88(1):43-54. PubMed ID: 8319355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Importance of nitric oxide in the coronary artery at rest and during pacing in humans.
    Nishikawa Y; Ogawa S
    J Am Coll Cardiol; 1997 Jan; 29(1):85-92. PubMed ID: 8996299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of nitric oxide to metabolic coronary vasodilation in the human heart.
    Quyyumi AA; Dakak N; Andrews NP; Gilligan DM; Panza JA; Cannon RO
    Circulation; 1995 Aug; 92(3):320-6. PubMed ID: 7634444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of nitric oxide in substance P-induced vasodilation differs between the coronary and forearm circulation in humans.
    Tagawa T; Mohri M; Tagawa H; Egashira K; Shimokawa H; Kuga T; Hirooka Y; Takeshita A
    J Cardiovasc Pharmacol; 1997 Apr; 29(4):546-53. PubMed ID: 9156366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Basal and flow-mediated nitric oxide production by atheromatous coronary arteries.
    Tousoulis D; Tentolouris C; Crake T; Toutouzas P; Davies G
    J Am Coll Cardiol; 1997 May; 29(6):1256-62. PubMed ID: 9137221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitric oxide production by coronary conductance and resistance vessels in hypercholesterolemia patients.
    Shiode N; Nakayama K; Morishima N; Yamagata T; Matsuura H; Kajiyama G
    Am Heart J; 1996 Jun; 131(6):1051-7. PubMed ID: 8644581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypomagnesemia inhibits nitric oxide release from coronary endothelium: protective role of magnesium infusion after cardiac operations.
    Pearson PJ; Evora PR; Seccombe JF; Schaff HV
    Ann Thorac Surg; 1998 Apr; 65(4):967-72. PubMed ID: 9564911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitric oxide activity in the atherosclerotic human coronary circulation.
    Quyyumi AA; Dakak N; Mulcahy D; Andrews NP; Husain S; Panza JA; Cannon RO
    J Am Coll Cardiol; 1997 Feb; 29(2):308-17. PubMed ID: 9014982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Important role of endogenous hydrogen peroxide in pacing-induced metabolic coronary vasodilation in dogs in vivo.
    Yada T; Shimokawa H; Hiramatsu O; Shinozaki Y; Mori H; Goto M; Ogasawara Y; Kajiya F
    J Am Coll Cardiol; 2007 Sep; 50(13):1272-8. PubMed ID: 17888845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitric oxide-mediated flow-dependent dilation is impaired in coronary arteries in patients with coronary spastic angina.
    Kugiyama K; Ohgushi M; Motoyama T; Sugiyama S; Ogawa H; Yoshimura M; Inobe Y; Hirashima O; Kawano H; Soejima H; Yasue H
    J Am Coll Cardiol; 1997 Oct; 30(4):920-6. PubMed ID: 9316519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of nitric oxide in coronary arterial vasomotion and the influence of coronary atherosclerosis and its risks.
    Goodhart DM; Anderson TJ
    Am J Cardiol; 1998 Nov; 82(9):1034-9. PubMed ID: 9817477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deficiency in nitric oxide bioactivity in epicardial coronary arteries of cigarette smokers.
    Kugiyama K; Yasue H; Ohgushi M; Motoyama T; Kawano H; Inobe Y; Hirashima O; Sugiyama S
    J Am Coll Cardiol; 1996 Nov; 28(5):1161-7. PubMed ID: 8890810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitric oxide mediates flow-dependent epicardial coronary vasodilation to changes in pulse frequency but not mean flow in conscious dogs.
    Canty JM; Schwartz JS
    Circulation; 1994 Jan; 89(1):375-84. PubMed ID: 8281673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Basal release of nitric oxide is decreased in the coronary circulation in patients with heart failure.
    Mohri M; Egashira K; Tagawa T; Kuga T; Tagawa H; Harasawa Y; Shimokawa H; Takeshita A
    Hypertension; 1997 Jul; 30(1 Pt 1):50-6. PubMed ID: 9231820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.